Anti-low-density lipoprotein receptor-related protein 4 (LRP4) antibodies were detected in approximately 2%–46% of MG patients who were negative for both AChR and MuSK antibodies (Higuchi et al., 2011). This evidence concerns the gene LRP4 and myasthenia gravis.